Epocrates to boost mobile healthcare support tools with IPO:
This article was originally published in Clinica
Executive Summary
Epocrates, a developer of mobile decision support software for the healthcare sector, is looking to raise $75m through an IPO on the Nasdaq Stock Exchange. The firm provides healthcare software that doctors can load onto hand-held, electronic point-of-care devices, such as PDAs or smartphones, and use to help in their clinical decision-making to enhance patient safety, comply with clinical standards of care, improve practice productivity, and better manage information. According to Epocrates, 50% of physicians use devices such as PDAs or smartphones in the US. The San Mateo, California-based firm will list under the ticker symbol "EPOC".
You may also be interested in...
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.